By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Daeduck BioCommunity
461-6 Jeonmin-dong, Yusung-gu
Taejon    305-390  Korea
Phone: 82-42-866-9300 Fax: 82-42-866-9301



Company News
CrystalGenomics Release: Polmacoxib Demonstrates Prevention And Treatment Effects In Colorectal Cancer 8/13/2014 12:36:20 PM
CrystalGenomics Nabs $12.8 Million From The Global Pharmaceutical Industry Development Fund 6/25/2014 8:43:42 AM
CrystalGenomics Announces Positive Results Of Phase 3 Trial Of Polmacoxib (CG100649) In Patients With Osteoarthritis 3/13/2014 9:35:26 AM
CrystalGenomics Acquires Hwail Pharmaceutical Co., Ltd. 8/26/2013 9:23:29 AM
CrystalGenomics Reports Positive Top-Line Data from Phase 2a Study of CG400549 in Patients with Complicated Acute Bacterial Skin and Skin Structure Infections Caused by MRSA 1/7/2013 11:19:30 AM
Sigma-Aldrich Corporation (SIAL) Release: SAFC Enters South Korean BioPharma Market With CrystalGenomics Agreement 10/30/2012 9:35:29 AM
CrystalGenomics Announces Positive Results from Phase 2b Osteoarthritis Study of CG100649 4/19/2012 9:45:26 AM
CrystalGenomics Initiates CG100649 Phase 2b Study in Patients with Osteoarthritis 6/1/2011 9:32:28 AM
CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study 5/12/2011 7:23:46 AM
CrystalGenomics to Present Preliminary Results from Recently Completed Supra-threshold Phase I MAD Study for CG100649, its Novel NSAID Candidate at the Arrowhead 4th Annual Pain Therapeutics Summit 10/4/2010 7:23:24 AM